Use of medications and resources for treatment of nausea, vomiting, or constipation in hospitalized patients treated with analgesics

Clinical Journal of Pain

Volumn 27, Issue 6, 2011, Pages 508-517

  Suh, Dong Churl ^a   Kim, Myoung S ^b   Chow, Wing ^b   Jang, Eun Jin ^c  

^a Chung Ang University   (South Korea)

^b RUTGERS UNIVERSITY   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

analgesics; constipation; nausea; opioid; vomiting

Indexed keywords

ANALGESIC AGENT; BROMFENAC; BUPRENORPHINE; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; DEZOCINE; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FENTANYL; FLURBIPROFEN; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; KETOPROFEN; LEVORPHANOL; METHADONE; MORPHINE; NALBUPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; SUFENTANIL; TRAMADOL; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONSTIPATION; COST OF ILLNESS; DRUG TOLERABILITY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VOMITING;

EID: 79958786285     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31820d9b76     Document Type: Article

References (49)

1. Centers for Disease Control and Prevention. National Center for Health Statistics, 2006 National Hospital Discharge Survey: Department of Health and Human Services, Atlanta, GA, July 2008.
2. Desbiens NA, Wu AW, Broste SK, et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. Crit Care Med. 1996;24:1953-1961. (Pubitemid 26418886)
3. Desbiens NA, Wu AW. Pain and suffering in seriously ill hospitalized patients. J Am Geriatr Soc. 2000;48:S183-S186. (Pubitemid 30266012)
4. van den Beuken-van Everdingen M, de Rijke J, Kessels A, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437-1449. (Pubitemid 47365475)
5. Whelan CT, Jin L, Meltzer D. Pain and satisfaction with pain control in hospitalized medical patients. Arch Intern Med. 2004;164:175-180. (Pubitemid 38140404)
6. DiPiro JT, Talbert RL, Yee CC, et al. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York, NY: McGraw- Hill; 2005.
7. Villars P, Dodd M, West C, et al. Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain. J Pain Symptom Manage. 2007;33:67-77. (Pubitemid 46017078)
8. Aparasu R, McCoy RA, Weber C, et al. Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life. J Pain Symptom Manage. 1999;18:280-288. (Pubitemid 29469706)
9. Allan L, Hays H, Jensen N-H, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001; 322:1-7.
10. Gnjidic D, Murnion BP, Hilmer SN. Age and opioid analgesia in an acute hospital population. Age Ageing. 2008;37:699-702.
11. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372-380. (Pubitemid 39550738)
12. Maier C, Hildebrandt J, Klinger R, et al. Morphine reponsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain-results of a double-blind placebocontrolled trial (MONTAS). Pain. 2002;97:223-233. (Pubitemid 34607218)
13. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005;7: R1046-R1051.
14. Roth SH, Fleischmann RM, Burch FX, et al. Around-theclock, controlled-release oxycodone therapy for osteoarthritisrelated pain. Arch Intern Med. 2000;160:853-860.
15. Peat S, Sweet P, Miah Y, et al. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily Repro-Dose morphine versus MST Continus. Eur J Clin Pharmacol. 1999;55:577-581. (Pubitemid 29489203)
16. Shord SS, Chew L, Villano J. Evaluation of opioid induced nausea and vomiting in sickle cell disease. Am J Hematol. 2008;83:196-199. (Pubitemid 351303942)
17. Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 2003;74:102-112. (Pubitemid 36951807)
18. White PF, Joshi GP, Carpenter RL, et al. A comparison of oral ketorolac and hydrocodone-acetaminophen for analgesia after ambulatory surgery: arthroscopy versus laparoscopic tubal ligation. Anesth Analg. 1997;85:37-43. (Pubitemid 27342272)
19. Gimbel JS, Brugger A, Zhao W, et al. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory surgery in adults. Clin Ther. 2001;23:228-241. (Pubitemid 32231113)
20. Van Dyke T, Litkowski LJ, Kiersch TA, et al. Combination oxycodone 5 mg/ibuprofen 400mg for the treatment of postoperative pain: a double-blind, placebo- and active-controlled parallel-group study. Clin Ther. 2004;26:2003-2014. (Pubitemid 40353610)
21. Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage. 2003;25:276-283. (Pubitemid 36287086)
22. Candrilli S, Davis K, Shrividya I. Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy. J Pain Palliat Care Pharmacother. 2009;23:231-241.
23. Premier. Premier research services. http://www.premierinc. com/quality-safety/tools-services/prs/index.jsp. Accessed on: April 2, 2010.
24. Main ML, Ryan AC, Davis TE, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol. 2008; 102:1742-1746.
25. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092-2099. (Pubitemid 38580152)
26. Schneeweiss S, Seeger JD, Landon J, et al. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008;358:771-783. (Pubitemid 351284455)
27. American Society of Health-System Pharmacists. American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2007.
28. Doyle D, Hanks G, Cherney I, et al. Oxford Textbook of Palliative Medicine. 3rd ed. New York: Oxford University Press; 2004.
29. Habib AS, Reuveni J, Taguchi A, et al. A Comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: a retrospective database analysis. Anesth Analg. 2007;104:548-551.
30. Swegle JM, Logemann C. Management of common opioidinduced adverse effects. Am Fam Physician. 2006;74:1347-1354. (Pubitemid 44607306)
31. Herndon CM, Jackson II KC, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy. 2002;22:240-250. (Pubitemid 34112884)
32. Saltelli A, Ratto M, Andres T, et al. Global Sensitivity Analysis. The Primer: John Wiley & Sons; 2008.
33. Hosmer DW, Lemeshow S. Applied Survivla Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wiley & Sons; 1999.
34. Lee ET. Statistical Methods for Survival Data Analysis. New York, NY: Wiley-Interscience Publication; 1992.
35. Manning WG, Mullahy J. Estimating log models: to transform or not to transform. J Health Econ. 2001;20:461-494. (Pubitemid 32515166)
36. Max EK, Hernandez JJ, Sturpe D, et al. Prophylaxis for opioid-induced constipation in elderly long-term care residents: a cross-sectional study of Medicare beneficiaries. Am J Geriatr Pharmacother. 2007;5:129-136. (Pubitemid 47277276)
37. Meuser T, Pietruck C, Radbruch L, et al. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93:247-257. (Pubitemid 32763182)
38. Sykes N. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med. 1998;12:375-382. (Pubitemid 28454405)
39. Grond S, Zech D, Lehmann KA, et al. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain. 1997;69:191-198. (Pubitemid 27081425)
40. Higgins PDR, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004; 99:750-759. (Pubitemid 38612817)
41. Morita T, Tsunoda J, Inoue S, et al. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage. 1999;18:338-346. (Pubitemid 29528469)
42. Droney J, Ross J, Gretton S. Constipation in cancer patients on morphine. Support Care Cancer. 2008;16:453-459.
43. Davies EC, Green CF, Mottram DR, et al. The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study. J Clin Pharm Ther. 2008;33:561-566.
44. Centers for Disease Control and Prevention. National Center for Health Statistics, 1999, National Hospital Discharge Summary: Annual Summary with Detailed Diagnosis and Procedure Data: Department of Health and Human Services, Atlanta, GA; September 2001 (PHS), 2001-1722.
45. Staats PS, Markowitz J, Schein J. Incidence of constipation associated with long-acting opioid therapy: a comparative study. South Med J. 2004;97:129-134. (Pubitemid 38222814)
46. Delaney CP, Chang E, Senagore AJ, et al. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database. Ann Surg. 2008;247:819-824. (Pubitemid 351591517)
47. Hauptman PJ, Swindle J, Burroughs TE, et al. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database. Am Heart J. 2008;155:978-985.
48. Miaskowski C, Cleary J, Burney R, et al. Guideline for the Management of Cancer Pain in Adults and Children. Glenview, IL: American Pain Society; 2005.
49. Yuan C-S. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Ann Pharmacother. 2007;41:984-993. (Pubitemid 46917625)